4.6 Article

Thymoquinone Alleviates Paclitaxel-Induced Peripheral Neuropathy through Regulation of the TLR4-MyD88 Inflammatory Pathway

Journal

ACS CHEMICAL NEUROSCIENCE
Volume 14, Issue 20, Pages 3804-3817

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.3c00411

Keywords

paclitaxel; peripheral neuropathy; thymoquinone; inflammation; pain; TLR4

Ask authors/readers for more resources

In this study, the neuroprotective effects and mechanisms of thymoquinone (TQ) in paclitaxel-induced peripheral neuropathy (PIPN) were investigated. The results demonstrated that TQ significantly alleviated pain behavior, modulated pathological changes, and reduced inflammatory factors induced by PIPN. Further experiments revealed that TQ exerts neuroprotective effects by regulating the TLR4/MyD88 and its downstream NF-kappa B and MAPKs inflammatory pathways. Molecular docking and cellular thermal shift assay confirmed the interaction between TQ and TLR4.
Paclitaxel-induced peripheral neuropathy (PIPN) is one of the common adverse effects during the paclitaxel (PTX) treatment of cancer. In this study, we investigated the neuroprotective effects and mechanisms of thymoquinone (TQ) in the PIPN model. Through pain behavioral assays and histological assessment, we demonstrated that TQ significantly alleviated the nociceptive behavior, modulated the pathological changes in peripheral nerves, and decreased the expression of inflammatory factors TNF-alpha, IL-1 beta, and IL-6 induced by PIPN in mice. In addition, TQ significantly reversed the reduced viability and inflammatory response of primary DRG neurons caused by PTX. Moreover, the gene expression of related pathways was detected by Western blot, qPCR, and immunofluorescence, and the results showed that TQ exerts neuroprotective effects by regulating TLR4/MyD88 and its downstream NF-kappa B and MAPKs inflammatory pathways in vivo and in vitro. The treatment with TLR4 antagonist TAK-242 further indicated the important role of the TLR4/MyD88 signaling pathway in PIPN. Furthermore, molecular docking and a cellular thermal shift assay were used to confirm the interaction of TQ with TLR4. In summary, our study shows that TQ can inhibit inflammatory responses against PIPN by regulating TLR4 and MyD88 and its downstream inflammatory pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available